Yi‐Lin Yang

1.3k total citations
45 papers, 1.0k citations indexed

About

Yi‐Lin Yang is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Yi‐Lin Yang has authored 45 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Cell Biology and 11 papers in Oncology. Recurrent topics in Yi‐Lin Yang's work include Hippo pathway signaling and YAP/TAZ (11 papers), Wnt/β-catenin signaling in development and cancer (7 papers) and Cancer-related gene regulation (6 papers). Yi‐Lin Yang is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (11 papers), Wnt/β-catenin signaling in development and cancer (7 papers) and Cancer-related gene regulation (6 papers). Yi‐Lin Yang collaborates with scholars based in China, United States and Taiwan. Yi‐Lin Yang's co-authors include Liang You, David M. Jablons, Zhidong Xu, Yuyuan Dai, Ping‐Chih Hsu, Yucheng Wang, Hui Li, Shu Liu, Bin Hu and Bin You and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yi‐Lin Yang

43 papers receiving 1.0k citations

Peers

Yi‐Lin Yang

ONCOL

PRM

IMMUN

Jinmei Yu China

Kun Gao China

Jonathan M. Goodwin United States

Kazuto Togitani Japan

Anders Bondo Dydensborg Canada

Carsten P. Ade Germany

Barbara Peter Austria

Tapan K. Maity United States

Kazuya Okada Japan

Laura Rossi Italy

Jinmei Yu China

Yi‐Lin Yang

616 ×1.1

209 ×0.6

234 ×1.0

ONCOL

195 ×1.3

PRM

190 ×2.0

IMMUN

Citations per year, relative to Yi‐Lin Yang Yi‐Lin Yang (= 1×) peers Jinmei Yu

Countries citing papers authored by Yi‐Lin Yang

Since Specialization

Citations

This map shows the geographic impact of Yi‐Lin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Lin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Lin Yang more than expected).

Fields of papers citing papers by Yi‐Lin Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Lin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Lin Yang. The network helps show where Yi‐Lin Yang may publish in the future.

Co-authorship network of co-authors of Yi‐Lin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Lin Yang. A scholar is included among the top collaborators of Yi‐Lin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Lin Yang. Yi‐Lin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Yi‐Lin, et al.. (2025). A temporal convolutional network-Transformer-CrossAttention model for state of charge estimation of lithium-ion batteries. Journal of Energy Storage. 141. 119417–119417.

Yang, Yi‐Lin, et al.. (2025). Estimation of lithium-ion batteries state-of-charge based on crayfish optimization algorithm and Kolmogorov-Arnold Network. Journal of Energy Storage. 132. 117836–117836. 1 indexed citations

Yang, Yi‐Lin, et al.. (2025). Improved crayfish optimization algorithm based on multimodal collaborative search and dynamic distribution perturbation for estimating State-of-Health of lithium-ion batteries. Swarm and Evolutionary Computation. 99. 102178–102178.

Zhou, Chengzhi, Haiyi Deng, Yi‐Lin Yang, et al.. (2024). Cancer therapy-related interstitial lung disease. Chinese Medical Journal. 138(3). 264–277. 3 indexed citations

Lin, Xinqing, et al.. (2023). Successful management of Epstein‑Barr virus‑associated severe checkpoint inhibitor‑related pneumonitis: A case report. Experimental and Therapeutic Medicine. 25(5). 222–222. 1 indexed citations

Lin, Xinqing, Haiyi Deng, Yi‐Lin Yang, et al.. (2022). Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis. Frontiers in Immunology. 12. 818492–818492. 20 indexed citations

Li, Suyang, Haiyi Deng, Yi‐Lin Yang, et al.. (2022). Immune thrombocytopenia in a small cell lung cancer patient treated with atezolizumab: a case report. Translational Lung Cancer Research. 11(11). 2346–2355. 5 indexed citations

Shi, Tingting, et al.. (2020). Comparative assessment of gut microbial composition and function in patients with Graves’ disease and Graves’ orbitopathy. Journal of Endocrinological Investigation. 44(2). 297–310. 31 indexed citations

Liu, Luwei, Yucheng Wang, Anatoly Urisman, et al.. (2019). Inhibition of cyclin‐dependent kinase 7 down‐regulates yes‐associated protein expression in mesothelioma cells. Journal of Cellular and Molecular Medicine. 24(1). 1087–1098. 7 indexed citations

10.

Shi, Tingting, Xin Zhong, Lin Hua, et al.. (2019). Alterations in the intestinal microbiota of patients with severe and active Graves’ orbitopathy: a cross-sectional study. Journal of Endocrinological Investigation. 42(8). 967–978. 46 indexed citations

11.

Hsu, Ping‐Chih, Zhen Huang, Yi‐Lin Yang, et al.. (2018). Inhibition of yes‐associated protein suppresses brain metastasis of human lung adenocarcinoma in a murine model. Journal of Cellular and Molecular Medicine. 22(6). 3073–3085. 26 indexed citations

12.

Yue, Hua, Yi‐Lin Yang, Qian Li, et al.. (2018). Oligomerization of Frizzled and LRP5/6 protein initiates intracellular signaling for the canonical WNT/β-catenin pathway. Journal of Biological Chemistry. 293(51). 19710–19724. 59 indexed citations

13.

Zhang, Wenqian, Yuyuan Dai, Ping‐Chih Hsu, et al.. (2017). Targeting YAP in malignant pleural mesothelioma. Journal of Cellular and Molecular Medicine. 21(11). 2663–2676. 50 indexed citations

14.

Woodard, Gavitt A., Yi‐Lin Yang, Liang You, & David M. Jablons. (2017). Drug development against the hippo pathway in mesothelioma. Translational Lung Cancer Research. 6(3). 335–342. 27 indexed citations

15.

Dai, Yuyuan, Shu Liu, Wenqian Zhang, et al.. (2016). YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells. Oncotarget. 8(3). 4096–4109. 46 indexed citations

16.

Zhang, Shulin, Yi‐Lin Yang, Yucheng Wang, et al.. (2014). CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells. Journal of Experimental & Clinical Cancer Research. 33(1). 93–93. 24 indexed citations

17.

Liu, Shu, David Hsieh, Yi‐Lin Yang, et al.. (2013). Coumestrol from the national cancer Institute’s natural product library is a novel inhibitor of protein kinase CK2. BMC Pharmacology and Toxicology. 14(1). 36–36. 47 indexed citations

18.

Zhi, Feng, Yan Xu, Yan Zhu, et al.. (2012). Activated β-catenin Forces N2A Cell-derived Neurons Back to Tumor-like Neuroblasts and Positively Correlates with a Risk for Human Neuroblastoma. International Journal of Biological Sciences. 8(2). 289–297. 14 indexed citations

19.

Yeh, Che‐Chung, Deepak Malhotra, Yi‐Lin Yang, et al.. (2012). MEK1‐induced physiological hypertrophy inhibits chronic post‐myocardial infarction remodeling in mice. Journal of Cellular Biochemistry. 114(1). 47–55. 9 indexed citations

20.

Widmer, Éric, et al.. (2006). Preferential infection of dividing cells by Cryptosporidium parvum. Parasitology. 133(2). 131–138. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact